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Background/aim: Aortic valve sclerosis (AVS) is characterized by lipid deposition and calcific infiltration on the edge of aortic leaflets
without significant restriction of motion. The SYNTAX Score (SS) is an important method for evaluating coronary artery disease (CAD).
Many studies showed that there is an important relation between the SS and undesired cardiac outcomes. In our study, we investigated
the correlation between the SS and AVS by including both ACS and stable CAD cases.
Materials and methods: We enrolled 543 patients with CAD who underwent coronary angiography into this cross-sectional study
between September 2013 and September 2014.
Results: The study population was divided into two groups according to SS values above and below 22. Diabetes mellitus (DM) incidence
was greater in the group with high SS values (26.3% vs. 19.2%, P = 0.052.). Left ventricular ejection fraction (LVEF) and glomerular
filtration rate were lower. Low-density lipoprotein cholesterol and triglyceride levels were lower while platelet counts were higher. In
multivariate analysis, for the stable coronary artery group AVS existence, platelet count, LVEF value, and chronic obstructive pulmonary
disease were found as independent predictors.
Conclusion: Our study results demonstrated that AVS is significantly associated with the complexity of CAD, especially in patients with
stable CAD. This study provides new information regarding the role of AVS in CAD complexity.
Key words: SYNTAX score, aortic valve sclerosis, coronary artery disease

1. Introduction
Aortic valve sclerosis (AVS) is defined as increased thickness and progressive calcification of aortic valves that
causes no obstruction to ventricular output (antegrade
velocity across the valve of less than 2.5 m/s) (1). Histopathological studies demonstrated that causes of AVS are
the accumulation of atherogenic lipoproteins, inflammatory cell infiltration, and microscopic calcification in the
extracellular matrix (2–4). An independent relation was
revealed between atherosclerosis risk factors and clinical
cardiovascular disease and AVS. This relation implies that
AVS and coronary artery disease (CAD) may have a similar mechanism of formation (5).
The Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) score
(SS) is an angiographic method for grading the complexity and intensity of CAD and provides more comprehen* Correspondence: drselimtopcu@yahoo.com
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sive evaluation of properties of the coronary lesion (6–8).
Some previous studies showed that a significant correlation between the SS and AVS was revealed in patients with
acute coronary syndrome (9). In our study, we investigated
the correlation between the SS and AVS by including both
ACS and stable CAD cases.
2. Materials and methods
We enrolled 543 patients with CAD (stable CAD and acute
coronary syndrome without ST segment elevation) who
underwent coronary angiography in this cross-sectional
study between September 2013 and September 2014. The
institutional ethics committee approved the study. Patients
with persistent ST segment elevation (n = 370), history of
percutaneous coronary intervention (n = 190) or coronary
artery bypass grafting (n = 77), rheumatic heart valve disease (n = 23), bicuspid aortic valve (n = 14), aortic valvular
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velocity above 2 m/s or mild to severe aortic stenosis (n =
14), and SS equal to 0 (n = 103) were excluded from the
study.
2.1. Data collection and clinical definitions
On admission, baseline clinical characteristics of all patients such as age, sex, body surface area (BSA), body mass
index (BMI), hypertension (HT), diabetes mellitus (DM),
chronic obstructive pulmonary disease (COPD), chronic
renal disease (CRD), glomerular filtration rate (GFR),
acute coronary syndrome (ACS), smoking, and previous
medications were recorded.
BSA (m2) was calculated according to the Mosteller
formula (height (cm) × weight (kg)/3600)½) and BMI was calculated
as weight (kg)/(height (m)2
). Hypertension was defined as having at
least 2 blood pressure measurements >140/90 mmHg or
using antihypertensive drugs. DM was defined as having
at least 2 fasting blood sugar measurements >126 mg/dL
or using antidiabetic drugs. COPD was defined according
to GOLD criteria (FEV1/FVC <0.70). CRD was defined as
GFR of <60 mL/min per 1.73 m2. GFR was calculated by
the Cockcroft–Gault formula ((140 – age) × (weight (kg))/
(72 × creatinine)). ACS was defined according to current guidelines (10,11). During admission to the hospital,
blood samples for complete blood count, low-density lipoprotein (LDL)- and high-density lipoprotein (HDL)-cholesterol, triglyceride, and creatinine were obtained from all
patients.
2.2. SYNTAX score
The SS is used to evaluate the complexity of CAD. Coronary arteries larger than 1.5 mm in diameter and with
stenosis of ≥50% were included for evaluation. The online
latest updated version (2.11) was used to calculate the SS
(www.SYNTAXscore.com, accessed in October 2014). SSs
were divided into 2 groups (low SYNTAX: <22, high SYNTAX: ≥22). All angiographic variables were computed by 2
cardiologists who were unaware of the study data (ST, UA).
In the case of disagreement the final decision was made by
consensus.
2.3. Aortic valve sclerosis
Aortic valves were evaluated from parasternal short axis
images. AVS was defined by focal areas of increased echogenicity and thickening of the aortic-valve leaflets without
restriction of leaflet motion (aortic velocity <2 m/s).
2.4. Statistical analysis
Continuous variables were expressed as mean ± standard
deviation or median (interquartile range) and categorical
variables were expressed as percentages. The distribution
of continuous variables was assessed by Kolmogorov–
Smirnov test. Continuous variables between two groups
were compared with the Student t-test or Mann–Whitney
U test as appropriate. Categorical variables were compared
with the chi-square test. To determine independent pre-

dictors of high SSs in the overall population and in the subgroups, multivariate regression analysis was performed.
Variables found to be significant (P < 0.05) in univariate
analysis were included in multivariate logistic regression
analysis. Sensitivity, specificity, negative predictive value
(NPV), and positive predictive value (PPV) for AVS in the
prediction of high SSs were estimated in 2 × 2 tables. A
2-sided P-value of <0.05 was considered significant. Data
were analyzed using SPSS 20.0 (IBM, Armonk, NY, USA).
3. Results
Our study includes 543 patients with CAD (median age
62 (52–72) years and 75.7% male). The study population
was divided into two groups based on SS values above and
below 22. DM incidence was greater in the high SS group
(26.3% vs. 19.2%, P = 0.052.). Left ventricular ejection
fraction (LVEF) and GFR were lower. LDL-cholesterol and
triglyceride levels were lower while platelet counts were
higher. Other basal clinical, angiographic, and laboratory
characteristics are summarized in Tables 1 and 2.
The overall AVS rate was revealed as 21.2% (n = 115)
including all groups. The high SS group had significantly
higher AVS positivity compared to the low SS group (31.3%
vs. 10.6%, P < 0.001 and OR = 3.8, 95% CI: 2.4–6.1) (Tables
1 and 2; Figure). The LVEF, AVS, GFR, platelet count, TG
and LDL levels, and DM existence were significant variables in univariate analysis. Multiple regression analysis
were performed with these variables in order to detect the
independent predictors of high SS. LVEF, AVS, GFR, platelet count, and LDL levels were evaluated as independent
predictors of high SS (Table 3). While there were 28 AVSpositive and 237 AVS-negative cases in the low SS group,
there were 87 AVS-positive and 191 AVS-negative cases in
the high SS group (Table 4). The sensitivity of AVS positivity to predict high SS was 31%, with a specificity of 89%.
PPV and NPV were detected as 75% and 55%, respectively.
In the analysis between AVS and SS parameters, a significant relationship was observed between AVS and bifurcation lesions, ostial lesions, long lesions, and total lesion
count (Table 5). In univariate analysis, by dividing patients
into two subgroups as the study population with ACS (n
= 105) vs. stable CAD (n = 438), DM, LDL and TG levels,
AVS existence, platelet count, LVEF value, and COPD existence were found to be significantly related for the stable
CAD group, whereas AVS existence, platelet count, LVEF
levels, GFR level, and WBC count were found significant
for the ACS group. In multivariate analysis, for the stable
CAD group, AVS existence, platelet count, LVEF value,
and COPD were found as independent predictors, whereas in the ACS group, platelet counts and LVEF values were
found as independent predictors (Table 6).
AVS was evaluated with echocardiography by two independent cardiologists unaware of the patient informa-
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Table 1. Baseline clinical characteristics according to SYNTAX score.
Variables

SYNTAX score
<22 (n = 265)

SYNTAX score
≥22 (n = 278)

P-value

Age (years)

62 (49–72)

63 (53–71)

0.474

Male, %

73.2

78.1

0.188

Body surface area, m2

1.88 (1.75–2.04)

1.88 (1.72–2.02)

0.625

Body mass index (kg/m )

26 (23–31)

27 (25–30)

0.235

Diabetes mellitus, %

19.2

26.3

0.052

2

Smoking, %

40.4

37.4

0.478

Hypertension, %

45.7

51.8

0.153

COPD, %

49.1

54.7

0.190

Chronic renal disease, %

15.8

17.6

0.579

Acute coronary syndrome, %

20.0

18.7

0.703

Aortic valve sclerosis, %

10.6

31.3

<0.001

Previous medications, %
ACE inhibitors
CCB
Beta blocker
Statin
Aspirin

22.6

28.1

0.147

8.7

9.7

0.677

6.0

8.3

0.313

14.7

19.1

0.177

16.6

17.6

0.752

40.4

37.4

0.478

COPD: Chronic obstructive pulmonary disease, ACE: angiotensin-converting-enzyme, CCB: calcium channel blockers.
Table 2. Baseline angiographic and laboratory characteristics according to SYNTAX scores.
Variables

SYNTAX score
<22 (n = 265)

SYNTAX score
≥22 (n = 278)

P-value

16.6

42.8

<0.001

Vessel, %
LMCA
LAD
CX
RCA

62.6

49.3

0.020

Treatment, PCI, %

66

26

<0.001

55 (48–62)

47 (39–53)

<0.001

LV-EF, %
eGFR, mL/min per 1.73 m
Creatinine, g/dL

2

73.2

85.3

0.001

56.6

53.2

0.431

92 (68–116)

82 (64–102)

0.030

0.88 (0.68–1.17)

0.96 (0.84–1.14)

0.030

Total cholesterol, mg/dL

158 (128–194)

150 (129–190)

0.499

LDL-cholesterol, mg/dL

95 (70–121)

71 (53–99)

<0.001

HDL-cholesterol, mg/dL

38 (32–46)

39 (32–47)

0.608

Triglyceride, mg/dL

121 (84–163)

99 (73–139)

0.002

Hemoglobin, g/dL

14.30 ± 2.43

14.7 ± 1.61

0.160

Platelets, 103/µL

174 (125–227)

244 (202–294)

<0.001

RDW, %

14 (13.6–14.4)

14 (13.3–14.6)

0.913

WBCs, 103/µL

8.6 (7.2–11)

8.3 (7.1–10.8)

0.643

LMCA: Left main coronary artery, LAD: left anterior descending, Cx: circumflex, RCA: right coronary artery, PCI:
percutaneous coronary intervention, LV-EF: left ventricle ejection fraction, e-GFR: estimated glomerular filtration rate
WBCs: white blood cells, RDW: red cell distribution width.
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Figure. The frequencies of aortic valve sclerosis between low
and high SYNTAX scores.
Table 3. Multivariate logistic regression analysis to detect the independent predictors of high SYNTAX scores.
Variables

Univariate OR (95% CI)

Univariate P-value

Multivariate OR (95% CI)

Multivariate P-value

LV-ejection fraction

-

<0.001

0.912 (0.880–0.945)

<0.001

Aortic valve sclerosis

3.80 (2.41–6.11)

<0.001

3.312 (1.467–7.480)

0.004

Glomerular filtration rate

-

0.030

0.985 (0.975–0.995)

0.003

Platelets

-

<0.001

1.011 (1.007–1.016)

<0.001

Triglyceride

-

0.002

1.004 (0.996–1.012)

0.300

Diabetes mellitus

1.494 (0.996–2.242)

0.052

1.186 (0.564–2.494)

0.653

LDL-cholesterol

-

<0.001

0.987 (0.975–0.999)

0.039

LV: Left ventricle, LDL: low-density lipoprotein.
Table 4. Numbers of aortic valve sclerosis cases between low and high SYNTAX scores.

Aortic valve
sclerosis

SYNTAX score <22

SYNTAX score ≥22

Total

No

237

191

428

Yes

28

87

115

Total

265

278

543

tion (İHT, SS). For interobserver agreement, 30 patients
were chosen randomly. There was perfect agreement between the two observers (kappa value = 0.842).

4. Discussion
In this study, we demonstrated that AVS existence is an
important independent predictor to demonstrate the com-
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Table 5. SYNTAX score parameters according to the presence or absence of aortic valve sclerosis.
SYNTAX variables

AVS (-) (n = 428)

AVS (+) (n = 114)

P-value

OR (95% CI)

Dominance %

84

88

0.306

-

Chronic total occlusion %

27.6

33.8

0.165

-

Bifurcation lesion %

47

64.3

0.010

2 (1.3–3.2)

Ostial lesion %

10

20.2

0.030

2.2 (1.2–3.9)

Diffuse small lesion %

19.4

27

0.690

-

Calcific lesion %

13.8

18.3

0.215

-

Thrombus %

29.7

28.7

0.880

-

Long lesion %

40.9

50.4

0.056

-

Number of total lesions (median)

5 (4–7)

7 (5–8)

<0.001

-

Table 6. Multivariate logistic regression analysis to detect the independent predictors of high SYNTAX score in stable coronary artery
disease and acute coronary syndrome subgroups.
Stable coronary artery disease

Acute coronary syndrome

Multivariate OR (95% CI) Multivariate P-value

Multivariate OR (95% CI) Multivariate P-value

Aortic valve sclerosis

3.114 (1.319–7.351)

0.010

16.2 (0.307–0.855)

0.169

Platelet count

1.012 (1.007–1.016

<0.001

1.018 (1.004–1.033)

0.014

LV-ejection fraction

0.920 (0.886–0.954)

<0.001

0.829 (0.719–0.955)

0.010

Glomerular filtration rate

–

–

0.974 (0.947–1.010)

0.062

WBCs

–

–

0.742 (0.504–1.093)

0.131

Diabetes mellitus

1.059 (2.364–0.474)
1.005 (0.979–0.992)

0.890

–

–

0.234

–

–

0.100

–

–

0.032

–

–

Variables

LDL-cholesterol
Triglyceride
COPD

1.015 (0.999–1.007)
2.083 (1.064–4.076)

LV: Left ventricle, WBCs: white blood cells, LDL: low-density lipoprotein, COPD: chronic obstructive pulmonary disease.

plexity of CAD. We also showed that AVS has significant
correlation with SYNTAX parameters like bifurcation lesions, ostial lesions, long lesions, and total lesion count.
We showed that the role of AVS to show the complexity
of CAD is especially valid for stable CAD, but no significant correlation was seen in the case of ACS with AVS and
complexity.
AVS is characterized by lipid deposition and calcific
infiltration on the edge of aortic leaflets without significant restriction of motion. AVS incidence has increased
with the aging population and common echocardiography
use (1,2,4). However, recent studies showed that AVS is
not only important because of aging; it may also advance
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aortic stenosis and may be related to CAD. Studies have
demonstrated that the risk factors for CAD formation and
progression may also be the risk factors for AVS development and progression to AD (2,4,5,7,12). We have shown
that CAD existence and severity and AVS are related to
each other. The mechanisms suggested for the similarity
between AVS and atherosclerosis are as follows: 1) AVS has
risk factors for atherosclerosis, 2) AVS and atherosclerosis
have similar histopathological characteristics, and 3) it was
shown that AVS and CAD are related to systemic atherosclerosis, just like the relation of carotid artery disease and
peripheral arterial disease with systemic atherosclerosis
(2,7,12–15).
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The SS is an important method for the evaluation of
both the complexity of CAD and determining the treatment protocol (6,8). Many studies showed that there is an
important relation between the SS and undesired cardiac
outcomes (8,16,17). To date, there are a few studies investigating the relation between the SS and AVS (2,9,15,18). In
these studies, ACS cases were included and the relation of
the SS with AVS was investigated. We included both AVS
and stable CAD, we investigated the relation between AVS
and the SS, and we found that AVS is an independent predictor to determine a high SS. In subgroup analysis according to ACS and CAD, we demonstrated that AVS existence
predicts a high SS in stable CAD, but not in ACS. However,
Korkmaz et al. (9,19) found an important relation between
AVS and the SS while including only ACS cases. There
are differences between the two studies, like some clinical risk factors and patient numbers. There are also differences for categorical SS values of the two studies. All these
factors may describe the discordance of the results of the
two studies (9,19). However, we suggest that, despite the
SAP group, AVS was not found predictive because those
patients in the ACS group were younger and had fewer
atherosclerotic risk factors when compared to stable CAD
patients. Previously defined and well-known traditional
atherosclerotic risk factors such as advanced age, male sex,
HT, DM, and smoking are related to stable CAD rather
than ACS, and these risk factors have strong correlations

with AVS. In previous studies, it has been demonstrated
that AVS and the SS may be related to cardiac mortality
and morbidity (2,6,8,9,16,18,19). We also found a strong
relation between AVS and the SS and this result supports
that AVS is related to the prevalence of CAD and undesired cardiovascular events.
Our study may have clinically important implications.
This study initially provides information about the complexity of CAD with AVS in stable CAD cases. However,
our study suggests that AVS does not give enough information about the complexity of CAD in ACS cases. For
interventional practice, AVS may be related to detection
of some complex conditions like chronic total occlusion,
bifurcation lesions, and long lesions. Our study has several
limitations. Our study was designed as a cross-sectional
study, and the number of patients with ACS was relatively low. The absence of an objective echocardiographic
method for evaluation of AVS is an important limitation,
although there was good inter- and intraobserver agreement. A similar limitation is also present for the SS.
In conclusion, our study results demonstrated that AVS
is significantly associated with the complexity of CAD, especially in patients with stable CAD. Moreover, the presence of AVS is correlated with complex lesions such as
chronic total occlusion, bifurcation lesions, and long lesions. This study provides new information regarding the
role of AVS in CAD complexity.
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